BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Alliance for Regenerative Medicine (ARM) Holds Second Annual Stem Cell Meeting on the Mesa Investor and Partnering Forum


8/21/2012 9:21:22 AM

WASHINGTON, DC--(Marketwire - August 21, 2012) - The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that the second annual Investor and Partnering Forum will take place during the Stem Cell Meeting on the Mesa on October 29 and 30, 2012. This meeting gathers the leadership of the regenerative medicine industry including executives from more than 110 ARM member companies and organizations. Situated amidst the nation's leading research cluster -- Southern California's Torrey Pines Mesa -- this forum provides a unique opportunity within the regenerative medicine field to facilitate translational research, encourage PI engagement with the business community, and provide the opportunity for hundreds of business, academic research and investor participants to connect for one-on-one meetings and strategic partnering.

This event was developed by ARM and the California Institute for Regenerative Medicine (CIRM) and will take place at the Sanford Consortium for Regenerative Medicine in La Jolla, CA immediately prior to the Stem Cell Meeting on the Mesa Scientific Symposium organized by the Sanford Consortium. In its 7th year, this nationally recognized Symposium is attended by leading scientists and researchers in the field, as well as participants from the business and patient advocacy communities. Combined, these meetings will attract over 800 attendees from around the globe, highlighting the promise and progress of this rapidly evolving, interdisciplinary field.

The Investor and Partnering Forum will include interactive panels addressing critical scientific, commercialization, regulatory and reimbursement issues, as well as feature presentations by leading companies and researchers seeking partners and investors. In addition, one-on-one meetings will be scheduled using a state-of-the-art partnering system to match and connect participants with prospective partners and investors.

Confirmed speakers include representatives from Athersys, CIRM, Life Technologies, Shire and PCT. For a full list of presenting companies or to learn more and register for the meeting please visit www.stemcellmeetingonthemesa.com. Registration is complimentary for credentialed members of the media and accredited investors.

About the Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization that promotes legislative, regulatory, reimbursement, and financing initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, and provides services to support the growth of its member companies and organizations. Prior to the formation of ARM, there was no advocacy organization operating in Washington, DC to specifically represent the interests of regenerative medicine companies, research institutions, investors, and patient groups supporting more rapid adoption of technologies in our field. To learn more about ARM or to become a member, visit www.alliancerm.org.


Media Contact:
Michelle Linn
Linnden Communications
Phone: 508-362-3087



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES